共 116 条
- [1] Bellentani S(2017)The epidemiology of non-alcoholic fatty liver disease Liver Int 37 81-84
- [2] Chalasani N(2016)Clinical practice guidelines for the management of non-alcoholic fatty liver disease Diabetologia 59 1121-1140
- [3] Younossi Z(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-357
- [4] Lavine JE(2019)Recent research trends and updates on nonalcoholic fatty liver disease Clin Mol Hepatol 25 1-11
- [5] Yoo JJ(2015)NAFLD: a multisystem disease J Hepatol 62 S47-S64
- [6] Kim W(2020)Nonalcoholic fatty liver disease and alcohol-related liver disease: from clinical aspects to pathophysiological insights Clin Mol Hepatol 26 728-735
- [7] Kim MY(2020)Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017 Lancet 395 709-733
- [8] Byrne CD(2017)Update on the burden of CKD J Am Soc Nephrol 28 1020-1022
- [9] Targher G(2012)Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function Nephrol Dial Transplant 27 1812-1821
- [10] Ikejima K(2017)Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease Nat Rev Nephrol 13 297-310